Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Monopar Therapeutics: Q2 Earnings Insights

  Monopar Therapeutics (NASDAQ:MNPR) reported its Q2 earnings results on Thursday, August 11, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
byBenzinga Insights
August 11, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

 

Monopar Therapeutics (NASDAQ:MNPR) reported its Q2 earnings results on Thursday, August 11, 2022 at 08:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Monopar Therapeutics missed estimated earnings by 4.76%, reporting an EPS of $-0.22 versus an estimate of $-0.21.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 9.19% increase in the share price the next day.

 

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Monopar Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Where Is The Cheapest Weed In America? A Close Look At Cannabis Pricing In PA And FL

By Nicolas Jose Rodriguez
August 17, 10:54 PM
Pablo Zuanic from Cantor Fitzgerald offered an industry update, covering cannabis pricing in Pennsylvania and Florida based on retailers’ menus. “Think of this report as 'food for thought' - we are not adjusting estimates or our investment views,” Zuanic said.

AYRWF